SGMT
Price
$2.96
Change
+$0.17 (+6.12%)
Updated
Apr 24, 02:47 PM (EDT)
Capitalization
89.5M
20 days until earnings call
VRDN
Price
$13.32
Change
-$0.19 (-1.41%)
Updated
Apr 24, 02:54 PM (EDT)
Capitalization
1.1B
13 days until earnings call
Ad is loading...

SGMT vs VRDN

Header iconSGMT vs VRDN Comparison
Open Charts SGMT vs VRDNBanner chart's image
Sagimet Biosciences
Price$2.96
Change+$0.17 (+6.12%)
Volume$4.27K
Capitalization89.5M
Viridian Therapeutics
Price$13.32
Change-$0.19 (-1.41%)
Volume$194
Capitalization1.1B
SGMT vs VRDN Comparison Chart
Loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGMT vs. VRDN commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGMT is a Buy and VRDN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (SGMT: $2.78 vs. VRDN: $13.51)
Brand notoriety: SGMT and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SGMT: 129% vs. VRDN: 65%
Market capitalization -- SGMT: $89.5M vs. VRDN: $1.1B
SGMT [@Biotechnology] is valued at $89.5M. VRDN’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGMT’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • SGMT’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGMT’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 5 bullish TA indicator(s).

  • SGMT’s TA Score: 4 bullish, 4 bearish.
  • VRDN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than SGMT.

Price Growth

SGMT (@Biotechnology) experienced а +37.62% price change this week, while VRDN (@Biotechnology) price change was +6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

SGMT is expected to report earnings on May 14, 2025.

VRDN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.1B) has a higher market cap than SGMT($89.5M). VRDN YTD gains are higher at: -29.525 vs. SGMT (-38.222). SGMT has higher annual earnings (EBITDA): -54.45M vs. VRDN (-266.36M). VRDN has more cash in the bank: 718M vs. SGMT (151M). SGMT has less debt than VRDN: SGMT (78K) vs VRDN (21.1M). VRDN has higher revenues than SGMT: VRDN (302K) vs SGMT (0).
SGMTVRDNSGMT / VRDN
Capitalization89.5M1.1B8%
EBITDA-54.45M-266.36M20%
Gain YTD-38.222-29.525129%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash151M718M21%
Total Debt78K21.1M0%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SGMTVRDN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARREF1.260.03
+2.76%
Amerigo Resources Ltd.
FRFHF1509.0415.54
+1.04%
Fairfax Financial Holdings Ltd.
ITOCY99.500.10
+0.10%
Itochu Corp.
BDNNY60.45-0.07
-0.12%
Boliden AB
SWISF0.02-0.01
-36.96%
SEKUR PRIVATE DATA LTD.

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with CCCC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+9.02%
CCCC - SGMT
41%
Loosely correlated
+3.21%
CRBU - SGMT
41%
Loosely correlated
+0.79%
VRDN - SGMT
41%
Loosely correlated
-1.82%
VOR - SGMT
40%
Loosely correlated
+8.96%
TRDA - SGMT
39%
Loosely correlated
N/A
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-1.82%
DNLI - VRDN
50%
Loosely correlated
+1.85%
AURA - VRDN
47%
Loosely correlated
+0.88%
TERN - VRDN
47%
Loosely correlated
+2.50%
CCCC - VRDN
45%
Loosely correlated
+3.21%
XENE - VRDN
45%
Loosely correlated
+2.23%
More